Jerome Wong - 16 Mar 2026 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Chief Financial Officer
Signature
/s/ Jerome Wong
Issuer symbol
EKSO
Transactions as of
16 Mar 2026
Net transactions value
+$15,500
Form type
4
Filing time
20 Mar 2026, 19:03:57 UTC
Previous filing
10 Dec 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Jerome Wong filed Form 4 for EKSO BIONICS HOLDINGS, INC. (EKSO) on 20 Mar 2026."

Quick Takeaways

  • This page summarizes Jerome Wong's Form 4 filing for EKSO BIONICS HOLDINGS, INC. (EKSO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 20 Mar 2026, 19:03.

What Changed

  • Previous filing in this sequence was filed on 10 Dec 2025.
  • Current net transaction value: +$15,500.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wong Jerome Chief Financial Officer 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong 20 Mar 2026 0001932326

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Purchase $15,500 +1,308 +45% $11.85 4,184 16 Mar 2026 By 401(k) F1, F2
holding EKSO Common Stock 24,771 16 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of common stock were acquired in connection with the Issuer's 401(k) contribution matching program.
F2 On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

Sponsored